Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jeffrey Conn

Showing results (71-80 of 416) with videos related to

Pageof 42
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 14, 2008
Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffoldSameer Sharma, Alice L Rodriguez, P Jeffrey Conn, et al.
Neuroscience Letters|September 28, 2011
Activation of group II metabotropic glutamate receptors induces long-term depression of excitatory synaptic transmission in the substantia nigra pars reticulataKari A Johnson, Colleen M Niswender, P Jeffrey Conn, et al.
Annual Review of Pharmacology and Toxicology|August 8, 2023
Targeting the Actions of Muscarinic Receptors on Dopamine Systems: New Strategies for Treating Neuropsychiatric DisordersEric J Nunes, Nii A Addy, P Jeffrey Conn, et al.
Neuropsychiatric Disease and Treatment|February 11, 2014
Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer's disease and schizophreniaDaniel J Foster, Derrick L Choi, P Jeffrey Conn, et al.
Advances in Pharmacology (San Diego, Calif.)|September 13, 2011
Allosteric modulation of metabotropic glutamate receptorsDouglas J Sheffler, Karen J Gregory, Jerri M Rook, et al.
ACS Chemical Biology|January 25, 2007
Preclinical drug discovery research and training at VanderbiltCraig W Lindsley, David Weaver, Carrie Jones, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 7, 2003
Distinct functional roles of the metabotropic glutamate receptors 1 and 5 in the rat globus pallidusOlga V Poisik, Guido Mannaioni, Stephen Traynelis, et al.
Journal of Psychopharmacology (Oxford, England)|July 18, 2014
Modulation of neuronal microcircuit activities within the medial prefrontal cortex by mGluR5 positive allosteric modulatorMarie Pollard, Jose Manuel Bartolome, P Jeffrey Conn, et al.
Nature Reviews. Drug Discovery|November 1, 2013
Bringing together the academic drug discovery communityBarbara S Slusher, P Jeffrey Conn, Stephen Frye, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 12, 2005
Group III metabotropic glutamate-receptor-mediated modulation of excitatory transmission in rodent substantia nigra pars compacta dopamine neuronsOrnella Valenti, Guido Mannaioni, Guy R Seabrook, et al.
Pageof 42

Showing results (71-80 of 416) with videos related to

Sort By:
Pageof 42
Bioorganic & Medicinal Chemistry Letters|June 14, 2008
Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffoldSameer Sharma, Alice L Rodriguez, P Jeffrey Conn, et al.
Neuroscience Letters|September 28, 2011
Activation of group II metabotropic glutamate receptors induces long-term depression of excitatory synaptic transmission in the substantia nigra pars reticulataKari A Johnson, Colleen M Niswender, P Jeffrey Conn, et al.
Annual Review of Pharmacology and Toxicology|August 8, 2023
Targeting the Actions of Muscarinic Receptors on Dopamine Systems: New Strategies for Treating Neuropsychiatric DisordersEric J Nunes, Nii A Addy, P Jeffrey Conn, et al.
Neuropsychiatric Disease and Treatment|February 11, 2014
Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer's disease and schizophreniaDaniel J Foster, Derrick L Choi, P Jeffrey Conn, et al.
Advances in Pharmacology (San Diego, Calif.)|September 13, 2011
Allosteric modulation of metabotropic glutamate receptorsDouglas J Sheffler, Karen J Gregory, Jerri M Rook, et al.
ACS Chemical Biology|January 25, 2007
Preclinical drug discovery research and training at VanderbiltCraig W Lindsley, David Weaver, Carrie Jones, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 7, 2003
Distinct functional roles of the metabotropic glutamate receptors 1 and 5 in the rat globus pallidusOlga V Poisik, Guido Mannaioni, Stephen Traynelis, et al.
Journal of Psychopharmacology (Oxford, England)|July 18, 2014
Modulation of neuronal microcircuit activities within the medial prefrontal cortex by mGluR5 positive allosteric modulatorMarie Pollard, Jose Manuel Bartolome, P Jeffrey Conn, et al.
Nature Reviews. Drug Discovery|November 1, 2013
Bringing together the academic drug discovery communityBarbara S Slusher, P Jeffrey Conn, Stephen Frye, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 12, 2005
Group III metabotropic glutamate-receptor-mediated modulation of excitatory transmission in rodent substantia nigra pars compacta dopamine neuronsOrnella Valenti, Guido Mannaioni, Guy R Seabrook, et al.
Pageof 42